About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Pfizer (PFE.N) reported Q3 revenue $16.58 bln, versus consensus $15.87 bln.

2026-11-03

Pfizer (PFE.N) reported Q3 revenue $16.58 bln, versus consensus $15.87 bln.

Other News
2026-11-03

Iranian President: War benefits no one.

Iranian President: War benefits no one.
2026-11-03

Iranian Deputy Foreign Minister Gharibabadi answered reporters' questions about the progress of negotiations and the clashes last night on Tuesday during a break at an event. He stated that interactions and information exchange are continuing through

Iranian Deputy Foreign Minister Gharibabadi answered reporters' questions about the progress of negotiations and the clashes last night on Tuesday during a break at an event. He stated that interactions and information exchange are continuing through intermediaries. Iran's "seven-day solution" is the basis for Iran's efforts to resolve the issue through Qatari mediation. He added that if there is interaction now, it is also based on that text, and feedback has been received. If Iran's demands are met, it can be said that a diplomatic understanding has been reached. Gharibabadi stated that Iran is not a warmonger, nor has it started a war; it was imposed on us by the enemy. If they claim to seek a diplomatic solution, they must abide by the demands that we have clearly stated. Gharibabadi stated that last night we witnessed the events announced by the US on Qeshm Island, and we are still in a state of war. In our view, the aggression against Iran has not ended. This is an important legal point: as long as military aggression has not completely and permanently ceased, Iran has the right to legitimate self-defense. He stated that Iran has consistently declared its commitment to diplomatic dialogue, but this is based on distrust of the United States. Iran is prepared for any situation, and if the United States seeks other solutions, Iran will resolutely defend itself.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.